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Genetic Susceptibility of the Arterial Wall Is an Important
Determinant of Atherosclerosis in C57BL/6 and FVB/N
Mouse Strains
Jeong Shim, Aase Handberg, Caroline O¨ stergren, Erling Falk, Jacob F. Bentzon
Objective—How genetic variations among inbred mouse strains translate into differences in atherosclerosis susceptibility
is of significant interest for the development of new therapeutic strategies. The objective of the present study was to
examine whether genetically controlled arterial wall properties influence atherosclerosis susceptibility in FVB/N (FVB)
and C57BL/6 (B6) apolipoprotein E knockout (apoE/) mouse strains.
Methods and Results—Common carotid artery segments from B6 apoE/, F1 apoE/, and FVB apoE/ mice were
transplanted to hybrid F1 apoE/ mice, which can accept grafts from both parental strains without adaptive immune
responses. The mice were fed a high-fat diet, and atherosclerosis was induced in the transplanted artery segments by
placement of a perivascular constrictive collar. Artery segments from B6 apoE/ mice developed much larger
atherosclerotic lesions than artery segments from FVB or F1 apoE/ mice. No differences in aortic arch atherosclerosis
of the recipient mice were observed between groups.
Conclusion—Genetically controlled factors acting at the level of the arterial wall are important determinants of atherosclerosis
susceptibility in FVB apoE/ and B6 apoE/ mice. (Arterioscler Thromb Vasc Biol. 2011;31:1814-1820.)
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The root cause of atherosclerosis is hypercholesterolemia,but some individuals do not develop atherosclerosis
despite severe hypercholesterolemia, whereas others develop
clinically significant atherosclerosis with low total cholester-
ol levels.1,2 Population studies have revealed that genetics is
an important determinant of this variable atherosclerosis
susceptibility, but much remains to be learned about the genes
involved and the way genetic variations are translated into
differences in atherosclerosis susceptibility.3,4
Apolipoprotein E knockout (apoE/) mice have high
levels of circulating cholesterol-rich lipoproteins caused by
the lack of apoE-mediated lipoprotein clearance,5 but the
extent of atherosclerosis development is strongly dependent
on the genetic background of the apoE/ mouse strain. For
instance, C57BL/6 (B6) apoE/ mice develop 9-fold more
atherosclerosis in the aortic root than FVB/N (FVB) apoE/
mice despite lower levels of total cholesterol.6 Hybrid
(B6xFVB)F1 (F1) apoE/ mice develop lesions of interme-
diate size.
Identification of the genes that determine such differences
in atherosclerosis susceptibility may direct attention to novel
drug targets.7 This is an unbiased approach not restricted to
building on prior knowledge and may therefore identify
atherosclerosis-modifying genes with previously unknown
functions. Furthermore, because functional variants of the
identified genes already exist among relatively healthy inbred
mouse strains, the strategy, at least to some extent, selects for
proteins that may be targeted by drugs without devastating
side effects.
Studies of FVBB6 intercrosses have led to the identifi-
cation of a number of quantitative trait loci (QTL) that
influence atherosclerosis susceptibility.8–10 A complementary
strategy to detect the causative gene variations is to identify
functional differences in the complex pathophysiology of
atherosclerosis between the strains. Using this approach,
recent studies of other strain combinations have shown that
the difference in atherosclerosis susceptibility between C3H
apoE/ and B6 apoE/ mice is mediated, at least in part,
by the reaction of vascular wall cells to hypercholesterol-
emia,11,12 whereas in another strain comparison, BALB/c
versus B6, the difference in atherosclerosis susceptibility
appeared to be mediated by other mechanisms.13
We have previously described a model in which site-
directed atherosclerosis is induced in transplanted common
carotid artery (CCA) segments by the application of a
constrictive perivascular collar,14 and we have shown that
smooth muscle cells (SMCs) and endothelial cells in this
model remain of local origin, with no contributions from
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putative circulating progenitor cells.14,15 In the present study,
we used this model to show that the low atherosclerosis
susceptibility of the FVB apoE/ mouse strains is, at least
partly, caused by a relative resistance of the arterial wall to
atherosclerosis formation.
Methods
Animals
All procedures were approved by the Danish Animal Experiments
Inspectorate. Female B6 apoE/ (B6.129P2-Apoetm1Unc, Taconic
M&B, Ry, Denmark) and male FVB apoE/ mice (kindly provided
by Jan L. Breslow, Rockefeller University, New York, NY) were
crossed to obtain F1 apoE/ hybrids. For all surgical procedures,
mice were anesthetized with isoflurane (induction 5%, maintenance
1.5% to 2.0%) and buprenorphine (0.1 mg/kg SC), and given
postoperative analgesics (Rimadyl, 5 mg/kg SC, repeated every 24
hours) for 3 days.
CCA Transplantation
CCA transplants were performed as previously described14 when the
mice were 8 weeks of age (see Figure 1 for schematic overview of
experiments). Briefly, the anesthetized donor mouse was killed by
exsanguination and flushed with 10 mL of heparin-saline (100
IU/mL) through the left ventricle. A segment of approximately 2 mm
of the right CCA of the donor mouse was harvested and stored in
ice-cold saline. The neck of the recipient mouse was incised through
the midline and the right CCA was dissected free of surrounding
tissue. Vessel clamps (ABB-11V, S&T, Neuhausen, Switzerland)
were applied 2 minutes after the injection of 200 IU/kg heparin IM.
A small piece of the recipient CCA was cut out, and the remaining
recipient vessel ends were flushed with saline to remove blood. The
donor graft was then interpositioned and anastomosed end-to-end
with 5 symmetrically positioned 11-0 nylon sutures (Ethicon, John-
son & Johnson, Birkerød, Denmark). Body weights of donor and
recipient mice were similar in all groups (see Supplemental Table,
available online at http://atvb.ahajournals.org).
Constrictive Collar Application
At 12 weeks of age, the CCA transplanted mice were put on a
high-fat diet (0.25% wt/wt cholesterol and 15% wt/wt cocoa butter,
diet 4021.06, Arie Blok BV, Woerden, the Netherlands), and 2
weeks later, atherosclerotic lesions were induced by applying a
constrictive perivascular collar around the distal part of the trans-
planted segments using a technique modified from von der Thu¨sen et
al.16 A silicone tube (inner diameter 0.31 mm, Helixmark, Helix
Medical Inc) was placed around the transplanted artery and secured
with two 8-0 nylon ligatures. Constrictive collars were also applied
to the CCA of FVB, F1, and B6 apoE/ mice that had not
undergone prior CCA transplantation.
Atherosclerosis Quantification
At 1, 3, or 6 weeks after collar insertion, mice were fasted from the
morning for 4 to 8 hours, anesthetized (5 mg of pentobarbital IP), and
exsanguinated by withdrawing blood from the right ventricle into
EDTA-coated tubes. The mice were then flushed with a cardioplegic
solution, perfusion-fixed at 100 mm Hg for 5 minutes with 4%
phosphate-buffered formaldehyde (pH 7.2) via the left ventricle, and
then immersed in the fixative for 6 hours before storage in cold
phosphate buffer. The right CCA with the transplanted segment was
removed and either dehydrated and embedded in paraffin (6 weeks)
or cryopreserved and embedded in OCT compound (1 or 3 weeks).
Sections were obtained at 50-m intervals, cutting upstream from
the proximal end of the constrictive collar and through the induced
lesion. After 5 levels, sections were obtained at 100-m intervals
until no more plaque was visible or until the proximal anastomosis
was reached. All sections were stained with orcein, and plaque sizes
were measured blindly using computer-assisted image analysis (ImageJ,
National Institutes of Health). Total plaque volume was calculated
according to the Cavalieri principle.17 Atherosclerosis in F1 apoE/
recipients euthanized 6 weeks after collar insertion was quantified by
illumination of cleaned, unstained, and unopened aortic arches as
previously described.18 Briefly, the arches were photographed with a
dissection microscope, and the area occupied by atherosclerotic
plaques, easily recognizable through the translucent wall, was
measured using ImageJ.
Figure 1. Overview of the experiments. A, Con-
strictive collar–induced atherosclerosis in CCA of
FVB, F1, and B6 mice. B and C, Constrictive col-
lar–induced atherosclerosis in CCA segments
transplanted from FVB, F1, and B6 mice into F1
mice. All mice were apoE/.
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Plaque Composition Analysis
Plaque composition was analyzed in plaques from the transplanted
FVB and B6 apoE/ CCA segments obtained at 1, 3, or 6 weeks
after collar insertion. Sections at100 m from the proximal end of
the constrictive collar were stained with Sirius Red for quantification
of collagen-rich connective tissue and with antibodies against
smooth muscle -actin (SMA) and Mac2 for counting of plaque
SMCs and macrophages, respectively.
The fraction of Sirius Red–staining plaque was analyzed using the
threshold color plugin for ImageJ (http://www.dentistry.bham.ac.uk/
landinig/software/software.html). SMA was detected using mouse
monoclonal anti-SMA (1:50, Clone 1A4, Dako, Glostrup, Den-
mark) after blocking of endogenous mouse immunoglobulins with
donkey anti-mouse Fab fragments (1:10, Jackson Immunoresearch)
and formaldehyde fixation (4%, 10 minutes). Mac2 was detected by
rat anti-mouse Mac2 antibody (1:500, CL8942AP, Cedarlane Labs,
Trichem Aps, Frederikssund, Denmark). Both primary antibodies
were followed by Texas Red–conjugated secondary antibodies
(1:400, Jackson Immunoresearch). Only SMCs and macrophage
profiles containing nuclei (4,6-diamidino-2-phenylindole–stained)
were counted.
Plasma Lipids
Cholesterol was measured in duplicates in EDTA-plasma from each
mouse by a manual cholesterol kit (enzymatic end point method)
from Randox (Crumlin). For profiling of lipoproteins by gel filtra-
tion, pools (100 L) of EDTA-plasma from FVB, F1, and B6
apoE/ mice (Figure 1A) were centrifuged through a Durapore
polyvinylidene difluoride membrane (pore size 0.22 m, Millipore-
Ultrafree Amicon, Billerica, MA), loaded on a Superose 6 10/300
GL column (GE Healthcare, Brøndby, Denmark) and separated at
room temperature at a flow rate of 0.25 mL/minute in 50 mmol/L
Tris, 0.3 mol/L NaCl and 0.1% human serum albumin, pH 7.2.
Elution fractions of 120 seconds were collected, and cholesterol
content was measured.
Statistical Analysis
Overall comparison between groups was performed with Kruskal-
Wallis test, except for cholesterol data where overall comparison was
performed with 1-way ANOVA. Test for Gaussian distribution was
performed using the Kolmogorov-Smirnov test implemented in the
Prism statistical software (GraphPad, San Diego, CA). If an overall
significant difference was found, pairwise group comparisons were
performed with the Dunn post test or the Tukey multiple comparison
test as appropriate. Two-sample nonparametric comparisons were
performed using Mann-Whitney tests. P0.05 was considered to
be statistically significant. In the first experiment, we excluded 2
mice (1 B6 and 1 FVB apoE/ mouse not listed in Figure 1A)
because morphology of the induced lesions and the fact that their
sizes were 28- and 539-fold larger than the second-largest lesions in
each group suggested that total occlusion had occurred.
Results
Plasma Cholesterol Analysis
Consistent with previous reports, plasma cholesterol levels or
lipoprotein profiles did not explain the difference in athero-
sclerosis development between FVB apoE/ and B6
apoE/ mouse strains. To the contrary, atherosclerosis-re-
sistant FVB apoE/ mice exhibited significantly higher
cholesterol levels in both very-low-density lipoprotein and
low-density lipoprotein fractions (Figure 2).
Atherosclerosis Induced by Constrictive Collars
It is generally assumed that the pathogenesis of collar-
induced atherosclerosis is similar to that of spontaneous
atherosclerosis, although this tenet is difficult to prove. Like
spontaneous atherosclerosis, collar-induced atherosclerosis
does not form in normocholesterolemic mice but is strictly
dependent on the presence of hypercholesterolemia, develops
at sites with low wall shear stress,19 and is initiated as foam
cell lesions that develop into fibroatheromas (Figure 3). This
is strikingly different from neointima induced by wire injury
or ligation, procedures that, curiously, lead to much larger
lesions in FVB than in B6 mice.20,21 To confirm that collar-
induced atherosclerosis reflected the differences previously
described for spontaneous atherosclerosis in the aortic root
(ie, lesion size in B6 apoE/ is much larger than in FVB
apoE/),6 we induced plaques in the carotids of B6, F1, and
FVB apoE/ mice. In FVB apoE/ mice, no foam cell
lesions or only very small ones were present after 6 weeks
(median lesion size 0 m3), whereas much larger and more
complex lesions that included fibrous tissue and often cho-
lesterol crystals developed in B6 apoE/ mice (median
0.6106 m3) (Figures 3A to 3C and 4). Lesion sizes in F1
apoE/ mice were intermediary (median 0.06106 m3).
We performed a similar study in male mice and obtained
similar results (data not shown).
The induction of atherosclerosis with the perivascular
collar is likely dependent on the degree of vessel constriction,
and because the collars were of fixed size, any systematic
differences in carotid artery diameter between mouse strains
might in itself have led to differences in lesion size. To
exclude this possibility, we measured inner circumference of
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Figure 2. FVB apoE/ mice have higher cholesterol levels in
very-low-density lipoprotein and low-density lipoprotein frac-
tions. Shown are fasting total cholesterol in individual mice (A)
and fast protein liquid chromatography profiles of pooled samples
(B) from FVB, F1, and B6 apoE/ mice at 20 weeks of age.
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the nontreated left carotid artery in the B6 apoE/
(1130156 m), F1 apoE/ (107346 m), and FVB
apoE/ (1156212 m) mice, but no significant differences
were detected. This is also consistent with previous reports on
vessel dimensions in these mouse strains.20 Furthermore, as a
proxy for vessel size, body weights of the different mouse
strains were not different at the time of collar placement or at
euthanization (Supplemental Table).
The Genotype of the Vessel Wall Determines
Susceptibility to Atherosclerosis
Atherogenesis is complex, with many participating cell types,
including bone marrow-derived cells (macrophages, lympho-
cytes, dendritic cells, mast cells) and vessel wall-derived cells
(SMCs, endothelial cells), and a plethora of potentially
important systemic factors, including hormones, metabolites,
and blood pressure. We hypothesized that factors inherent to
the local vessel wall may control atherosclerosis susceptibil-
ity in B6 and FVB apoE/ mice and performed transplants
of carotid segments from FVB, F1, and B6 apoE/ strains
into F1 apoE/ mice to test this idea.
Hybrid F1 apoE/ mice can receive tissues from both
parental strains without adaptive immune responses,12 and
although there is a potential for natural killer cell reactions
toward the FVB apoE/ and B6 apoE/ transplants in our
experimental design,22 we did not observe signs of allograft
vasculopathy either by visual inspection during surgery when
collars were applied (6 weeks after transplantation) or, more
directly, by histology of B6 (n3) or FVB apoE/ trans-
plants (n3) 1 week after collar placement (7 weeks after
transplantation) (Supplemental Figure I).
Six weeks after collar insertion, atherosclerotic plaques had
formed within the transplanted segments extending from imme-
diate proximal to the inserted collar toward the proximal anas-
tomosis. Lesions in the F1 apoE/ arterial segments trans-
planted into F1 apoE/ mice were larger than lesions induced
in F1 apoE/ mice without preceding transplantation (P0.06
by Mann-Whitney test). Also, lesions in both B6 apoE/ and
FVB apoE/ arterial segments transplanted into F1 apoE/
mice were significantly larger than similar lesions induced in B6
apoE/ and FVB apoE/ mice (P0.0007 and P0.0003,
respectively, by Mann-Whitney tests).
Interestingly, when segments transplanted into F1 apoE/
mice were compared, plaques were dramatically larger in B6
apoE/ segments (median 55.8106 m3) compared with
both FVB (median 1.7106 m3) and F1 apoE/ (median
0.6106 m3) segments (Figures 3D to 3F and 5A), indicat-
ing that proatherogenic gene variants acting recessively with
respect to the B6 allele affect the susceptibility of the vessel
wall to atherosclerosis. No differences in recipient atheroscle-
rosis in F1 apoE/ mice were seen (Figure 5B and Supple-
mental Figure II).
Differentially Regulated Mechanisms
To investigate whether plaque composition was influenced by
the genotype of the arterial wall, we analyzed the develop-
ment and composition of plaques in transplanted FVB and B6
apoE/ vessel segments at a fixed distance (100 m)
upstream from the collar. The vast difference in plaque
growth induced by collar insertion (Figure 6A) biases the
comparison of plaque composition because of the association
Figure 3. The genotype of the arterial wall
is an important determinant of plaque
development. Shown are atherosclerotic
lesions induced by constrictive collars in
the native CCA of FVB (A), F1 (B), and B6
(C) mice and in CCA segments trans-
planted from FVB (D), F1 (E), and B6 (F)
mice into F1 mice. Images were chosen
to reflect median lesion size in each
group. Sections were stained with orcein.
Scale bars100 m.
Figure 4. FVB apoE/ mice are resistant to constrictive collar–
induced atherosclerosis. Shown are the volumes of lesions
induced by placement of constrictive collars in the native CCA
of FVB, F1, and B6 apoE/ mice. #Large lesions, 1 F1 apoE/
mouse with 3.5106 m3 and 1 B6 apoE/ with 7.3106 m3
in total lesion volume. Bars indicate median in each group.
**P0.01 for pairwise comparison between FVB and B6
apoE/ mice using the Dunn post test.
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between plaque size and composition during atherogenesis in
mice. Early and small lesions contain mostly foam cell
macrophages, whereas more mature and bigger plaques
contain more SMCs and fibrous tissue. Instead of comparing
plaque composition at single time points, where plaque size is
a tremendous source of bias, we therefore pooled observa-
tions and studied the relationship between plaque size and
plaque composition. No apparent differences in plaque com-
position of similar-sized lesions between FVB and B6
apoE/ vessel segments were noted (Figure 6B to 6G).
Discussion
The mechanisms mediating the difference in atherosclerosis
development between B6 apoE/ and FVB apoE/ mice
are not understood. Even though the FVB apoE/ strain has
even higher levels of both very-low-density lipoprotein and
low-density lipoprotein cholesterol, it develops little athero-
sclerosis. Our present study indicates that genetically con-
trolled properties of the arterial wall make FVB apoE/
mice relatively less prone to atherosclerosis.
Strategies to Identify Susceptibility Genes
Several studies have searched for gene variants that influence
atherosclerosis susceptibility in inbred mouse strains using
QTL analysis.8,9 Several susceptibility genes have been iden-
tified in this way,23,24 including genes not previously known
to be involved in atherosclerosis, but a number of challenges
limit progress. One difficulty is the identification of causative
genes among a large number of candidates within QTL
regions. Novel steps, including expression QTL and more
sophisticated crosses, have been taken to reduce this problem
but it remains a formidable effort.25,26 A more fundamental
limitation is the complex genetic architecture of many traits,
including atherosclerosis susceptibility. Rather than being
caused by few genetic variants with large effects, atheroscle-
rosis susceptibility in inbred mice and humans result from the
integration of numerous small-effect gene variations, most of
them undetectable by QTL analysis using conventional sam-
ple sizes. For example, in an F2 intercross of FVB apoE/
and B6 apoE/ mice, Dansky et al found only 1 genome-
wide significant QTL, and in fact, genetic variation at this
locus does not contribute to the relative atherosclerosis
resistance of the FVB apoE/ strain because F2 mice with
the FVB allele develop more atherosclerosis than F2 mice
with the B6 allele.8
Strategies to Identify Biological Pathways
Even though the genetics of atherosclerosis is complex, many
genetic variations with subtle individual effects may con-
verge on a limited set of pathways that may be targets for
efficient antiatherogenic intervention. Complementary ap-
proaches, such as the one taken in the present study, may be
needed to identify these pathways when no large-effect gene
variations, detectable by genetic techniques, reveal their
nature. The present study indicates that genetically controlled
properties of the arterial wall renders FVB arteries dramati-
cally less prone to plaque development compared with B6
arteries. These properties may include (1) differential regu-
lation or coding-sequence differences of genes that are
expressed in SMCs or endothelial cells and involved in the
atherosclerotic process or (2) genes that control the structure
of the normal arterial wall, eg, extracellular matrix composi-
tion, making it more or less susceptible to atherosclerosis in
the face of hypercholesterolemia. Our investigation of 3
candidate vessel wall-controlled processes (macrophage re-
cruitment, SMC recruitment, and fibrous tissue production)
did not reveal obvious candidates for the underlying mecha-
nism, but our rather coarse approach does not, on the other
hand, rule out that these processes may be involved.
Candidate Genes
The present study suggests that genes that are expressed in
SMCs or endothelial cells and have cis-expression QTL in
these cell types are particularly interesting candidates for
causative susceptibility genes in QTL regions identified
previously in B6 and FVB crosses. One such gene may be
Adam17. In a recent study, Teupser et al identified a QTL
A
B
Figure 5. The resistance of FVB apoE/ mice to atherosclero-
sis is inherent to the vascular wall. A, Lesion volumes induced
by placement of constrictive collars in CCA segments of FVB,
F1, and B6 apoE/ mice after transplantation into F1 apoE/
mice. **P0.01, ***P0.001 for pairwise comparisons using the
Dunn post test. B, Recipient atherosclerosis in the aortic arch
was not different between groups. ns indicates nonsignificant by
the Kruskal-Wallis test. Bars indicate median in each group.
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region on chromosome 12 in an intercross between FVB and
B6 low-density lipoprotein receptor–knockout mice.9 Con-
genic mice revealed that B6/B6 alleles at this locus increased
lesion development by approximately 50% compared with
the B6/FVB genotype, and subsequent studies showed that
the Adam17 gene, which is located in the region, is differen-
tially expressed between B6 and FVB aortas and had a
cis-expression QTL in liver tissue.10 Although this gene
cannot alone explain the vast difference in arterial suscepti-
bility observed between B6 and FVB mice, it may direct
attention to vascular cell-exerted control of the local cytokine
environment as a candidate mechanism.
Limitations
Atherosclerotic lesions develop at branch sites and in curva-
tures of the vascular tree where special flow fields character-
ized by low wall shear stress prevail.27,28 Consistently, the
straight segment of the CCA in apoE/ mice is normally
resistant to atherosclerosis but can be turned into an athero-
sclerosis-susceptible region by placement of a constrictive
collar that lowers wall shear stress and causes other changes
to the flow field immediate proximal to the collar.19 Although
this process bears much resemblance to spontaneous athero-
sclerosis in terms of both etiology and pathogenesis, there
might be significant differences, and proper caution should thus
be exerted when extrapolating from this experimental model.
Another important aspect of our findings is that is that
lesions induced by constrictive collars in normal carotid
arteries were smaller than those induced in transplanted
segments despite the fact that the collars were applied at the
same age and for the same period of time. One contributing
factor may be that transplanted CCA segments were more
difficult to dissect free of periadventitial tissue, and it is
plausible that placement of the collar therefore caused a
relatively higher degree of flow disturbance, leading to a
greater atherogenic stimulus. Less than perfect anastomoses
may also in itself have contributed to reduced blood flow.
Furthermore, even though transplantation of parental solid
tissue into hybrid mice does not elicit B or T cell–mediated
immunity, it may trigger natural killer cells as recently shown
for B6 hearts that developed significant allograft vasculopa-
thy by week 5 to 8 after transplantation into (B6xB/c)F1
hybrid mice.22 In our study, lesions clearly developed as a
result of collar placement (Figure 6A), and no allograft
vasculopathy was present 7 weeks after transplantation. It
remains possible, however, that more subtle influences of
natural killer cells, eg, the secretion of proinflammatory
cytokines, may have accelerated lesion formation after ath-
erosclerosis induction and, if this were to be the case, that
potential differences in the magnitude of such activity might
have influenced the results of the present and similar studies
in the field.12
Conclusions
Our experiments indicate that genetically controlled proper-
ties of the arterial wall mediate a major part of the difference
in atherosclerosis susceptibility between FVB apoE/ and
B6 apoE/ inbred mice.
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Figure 6. Composition of plaques in transplanted
FVB and B6 apoE/ CCA segments. A, Lesion
growth. B to D, The number of macrophages and
SMCs, and the area of Sirius Red–staining
(collagen-rich) tissue were measured in adjacent
sections at 100 m proximal to the collar and
plotted against plaque size. B6 data points are
shown in filled symbols and comprise plaques har-
vested 1 week (F), 3 weeks (), and 6 weeks ()
after collar placement. FVB data points are shown
in similar open symbols (E for 1 week,  for 3
weeks, and ƒ for 6 weeks after collar placement).
Plaques in FVB apoE/ CCA segments contained
fewer macrophages, SMCs, and collagen-rich tis-
sue but were also much smaller, and when
plaques of similar sizes were compared, no obvi-
ous compositional differences were noted. E, Im-
munofluorescence detection of Mac2 to identify
macrophages. F, Immunofluorescence detection of
SMA to identify SMCs. G, Sirius Red–stained
section as examined with polarized microscopy to
analyze the amount and distribution of collagen-
rich tissue in plaques. The lumen, the internal elas-
tic lamina, and the external elastic lamina are
traced (gray dotted line). The adventitia of the
transplanted segments was particularly collagen-rich.
L indicates lumen; P, plaque; M, media; A, adventitia.
Scale bars50 m (E and F) or 200 m (G).
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[1] 
 
Supplemental Material. 
 
Supplementary Table. Body weights of mice 
A.  
Collar-Induced Lesions  
  Weight at collar 
application (g) 
Weight at 
euthanization (g) 
FVB apoE-/- (n=7)   22,7 (21,9-24,7) 27,0 (24,5-30,0) 
F1 apoE-/- (n=10)   23,8 (22,4-24,3) 26,6 (25,3-26,9) 
B6 apoE-/- (n=7)   24,1 (23,3-25,4) 25,5 (25,1-27,3) 
B. 
CCA Transplants 
   Weight at CCA transplantation (g)  Weight at collar  
application (g) 
Weight at  
euthanization (g) Donor mouse Recipient mouse 
FVB apoE-/- → F1 apoE-/- (n=13) 20,8 (20,2-22,3) 21,3 (20,4-22,1) 23,8 (22,7-25,2) 26,7 (25,3-27,9) 
F1 apoE-/- → F1 apoE-/- (n=18) 21,2 (19,6-21,7) 20,8 (19,3-21,9) 23,3 (21,5-24,2) 25,6 (24,9-27,2) 
B6 apoE-/- → F1 apoE-/- (n=15) 20,3 (19,4-21,4) 21,0 (19,9-21,9) 23,2 (22,1-24,1) 26,3 (25,5-27,5) 
Values are median (interquartile range) for weight. CCA, common carotid artery 
 
Supplementary Figure I 
 
Supplementary Figure 1. Cross-sections of FVB apoE-/- (A) and B6 apoE-/- (B) carotid segments 7 weeks 
after transplantation into F1 apoE-/- mice and 1 week after collar application. Sections are taken 500 µm 
upstream to the collar. No allograft vasculopathy lesions are seen. Scale bar 100 µm.  
 
[2] 
 
Supplementary Figure II 
 
Supplementary Figure 2. Unstained and unopened aortic arch and major branches from an F1 
apoE-/- recipient mouse. The non-pellucid atherosclerotic plaques are easily visible through the 
translucent arterial wall. The area occupied by plaque in the aortic arch (from above the aortic 
leaflets to 1 mm below the left subclavian artery) and in the first 1 mm of each of the branches was 
measured. Scale bar 1 mm.  
  
